Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate

Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate

US Patent 11795236 · Granted Oct 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of antibody-drug conjugate and tubulin inhibitor2025
Protein recognizing drug moiety of antibody-drug conjugate2025
Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibo2025
Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibo2025
Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibo2025
Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibo2025
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diaze2025
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diaze2025
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diaze2025
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diaze2025
Antibody-drug conjugate2025
Antibody-drug conjugate2025